RxDoctor Payments Data

Ashokkumar Shah, MD

Psychiatry · Kenosha, WINPI 1730246380

Payments from drug & device makers

$1,455in general payments, 2019–2025

Across 81 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$204
  • AbbVie$178
  • Lundbeck LLC$133
  • Otsuka America Pharmaceutical, Inc.$127
  • Alkermes, Inc.$124
  • Neurocrine Biosciences, Inc.$114
  • plus $575 from 13 others

What the payments were for

  • Food & beverage$1,43799%
  • Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,455 in reported general payments places this provider in the 80th percentile of 543 psychiatry providers in Wisconsin.

See all psychiatry providers in Wisconsin

Medicare billing

Part B allowed, 2024
$32,508
Medicare patients
85
Services billed
341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl46$62,224
Risperdal ConstaRisperidone Microspheres18$44,581
Invega SustennaPaliperidone Palmitate11$25,393
Ziprasidone Hcl39$7,159
Asenapine Maleate24$6,893
BelsomraSuvorexant15$6,222
Lurasidone Hcl37$3,840
Aripiprazole49$3,772
Clozapine70$3,651
Venlafaxine Hcl ErVenlafaxine Hcl116$3,576
Olanzapine94$3,039
Fluphenazine Decanoate24$2,539
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine15$2,213
Bupropion XlBupropion Hcl131$2,002
Haloperidol Decanoate39$1,911

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonRisperdal Consta, Invega Sustenna$204$69,97329 claims
AbbVieVraylar$178$62,22446 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 543 psychiatry providers in Wisconsin.

Other psychiatry in Kenosha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →